Cargando…
“Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235291/ https://www.ncbi.nlm.nih.gov/pubmed/25478327 http://dx.doi.org/10.3389/fonc.2014.00334 |
| _version_ | 1782345001218342912 |
|---|---|
| author | Tagliabue, Elda Campiglio, Manuela |
| author_facet | Tagliabue, Elda Campiglio, Manuela |
| author_sort | Tagliabue, Elda |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4235291 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42352912014-12-04 “Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas Tagliabue, Elda Campiglio, Manuela Front Oncol Oncology Frontiers Media S.A. 2014-11-18 /pmc/articles/PMC4235291/ /pubmed/25478327 http://dx.doi.org/10.3389/fonc.2014.00334 Text en Copyright © 2014 Tagliabue and Campiglio. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Tagliabue, Elda Campiglio, Manuela “Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas |
| title | “Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas |
| title_full | “Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas |
| title_fullStr | “Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas |
| title_full_unstemmed | “Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas |
| title_short | “Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas |
| title_sort | “omics” and immunologic approaches to optimizing cure rates in her2-positive breast carcinomas |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235291/ https://www.ncbi.nlm.nih.gov/pubmed/25478327 http://dx.doi.org/10.3389/fonc.2014.00334 |
| work_keys_str_mv | AT tagliabueelda omicsandimmunologicapproachestooptimizingcureratesinher2positivebreastcarcinomas AT campigliomanuela omicsandimmunologicapproachestooptimizingcureratesinher2positivebreastcarcinomas |